一般演題1-7A 悪性リンパ腫：臨床試験

[OS1-7A-2] Japanese iNHL patients receiving lenalidomide/rituximab (R²) from AUGMENT (R/R) and RELEVANCE (1L)

Yasuhito Terui¹, John P. Leonard², Nathan H. Fowler³, Franck Morschhauser⁴, Koji Izutsu⁵, Yosuke Minami⁶, Noriko Fukuhara⁷, Tatsuro Jo⁸, Go Yamamoto⁹, Takayuki Ishikawa¹⁰, Tsutomu Kobayashi¹¹, Toru Kiguchi¹², Hirokazu Nagai¹³, Kiyoshi Ando¹⁴, Hisayuki Yokoyama¹⁵, Michiaki Koike¹⁶, Koji Kato¹⁷, Tomoko Ohtsu¹⁸, Stacey Kalambakas¹⁹, Pierre Fustier²⁰, Shuichi Midorikawa¹⁸, Kensei Tobinai⁵ (1.Department of Hematology Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Koto-ku, Japan, 2.Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY, United States of America, 3.Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America, 4.University of Lille, CHU Lille, EA 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associee, Lille, France Metropolitan, 5.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 6.Department of Hematology, National Cancer Center Hospital East, Chiba, Japan, 7.Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan, 8.Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan, 9.Department of Hematology, Toranomon Hospital, Tokyo, United States of America, 10.Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan, 11.Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 12.Department of Hematology, Chugoku Central Hospital, Fukuyama, Japan, 13.Department of Hematology and Oncology Research, Nagoya Medical Center, Clinical Research Center, Nagoya, Japan, 14.Department of Hematology and Oncology, Tokai University School of Medicine, Tokyo, Japan, 15.Department of Hematology, National Hospital Organization Sendai Medical Center, Sendai, Japan, 16.Department of Hematology, Juntendo University Shizuoka Hospital, Tokyo, Japan, 17.Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Fukuoka City, Japan, 18.Celgene K.K., Tokyo, Japan, 19.Celgene Corporation, Summit, NJ, United States of America, 20.Celgene Corporation, Boudry, Swiss Confederation)